Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment
Addiction Biology · 2024-01 · 29 (1)
DOI: 10.1111/adb.13355 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Addiction Biology, online erschienen am 19.12.2023. Verfasst von Kelly E Dunn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Hydromorphone, Receptors, Opioid, mu. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Allelic variations in the A118G SNP of the OPRM1 gene change opioid signaling; however, evaluations of how allelic differences may influence opioid effects are lacking. This human laboratory paradigm examined whether the AA versus AG/GG genotypes determined opioid response profiles. Individuals with limited opioid exposure (N = 100) completed a five‐day within‐subject, double‐blind, placebo‐controlled, residential study. Participants were admitted (Day 1), received 4 mg hydromorphone (Day 2) and 0 mg, 2 mg and 8 mg hydromorphone in randomized order (Days 3–5) and completed self‐reported visual analog scale (VAS) ratings and Likert scales, observed VAS, and physiological responses at baseline and for 6.5 h post‐dose. Outcomes were analysed as peak/nadir effects over time as a function of genotype (available for N = 96 individuals; AG/GG = 13.5%, AA = 86.4%). Participants with AG/GG rated low and moderate doses of hydromorphone as significantly more positive (e.g., Good Effects VAS, coasting, drive, friendly, talkative, stimulation) with fewer negative effects (e.g., itchy skin, nausea, sleepiness), and were also observed as being more talkative and energetic relative to persons with AA. Persons with AG/GG were less physiologically reactive as determined by diastolic blood pressure and heart rate, but had more changes in core temperature compared with those with AA. Persons with AA also demonstrated more prototypic agonist effects across doses; persons with AG/GG showed limited response to 2 mg and 4 mg. Data suggest persons with AG/GG genotype experienced more pleasant and fewer unpleasant responses to hydromorphone relative to persons with AA. Future studies should replicate these laboratory findings in clinical populations to support a precision medicine approach to opioid prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Mental Health, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
ORCID-Profile: Kelly E Dunn
Förderung
- NIDA NIH HHS
- NIH HHS
- National Institute on Drug Abuse
- National Institutes of Health
Zitieren
APA
Dunn, K. E., Huhn, A. S., Finan, P. H., Mange, A., Bergeria, C. L., Maher, B. S., Rabinowitz, J. A., Strain, E. C., & Antoine, D. (2024). Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment. Addiction Biology, 29(1). https://doi.org/10.1111/adb.13355
Vancouver
Dunn KE, Huhn AS, Finan PH, Mange A, Bergeria CL, Maher BS, et al. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment. Addiction Biology. 2024;29(1). doi:10.1111/adb.13355
BibTeX
@article{Dunn2024,
author = {Dunn, Kelly E and Huhn, Andrew S and Finan, Patrick H and Mange, Ami and Bergeria, Cecilia L and Maher, Brion S and Rabinowitz, Jill A and Strain, Eric C and Antoine, Denis},
title = {Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment},
journal = {Addiction Biology},
year = {2024},
volume = {29},
number = {1},
doi = {10.1111/adb.13355}
}
EUVIMED